Li Bo-Wen, Wei Kun, Liu Qi-Qi, Sun Xian-Ge, Su Ning, Li Wen-Man, Shang Mei-Yun, Li Jin-Mi, Liao Dan, Li Jin, Lu Wei-Ping, Deng Shao-Li, Huang Qing
Department of Laboratory Medicine, Daping Hospital, Army Medical University, Chongqing, China.
Department of Nursing, Children's Hospital of Chongqing Medical University, Chongqing, China.
Front Bioeng Biotechnol. 2021 Oct 27;9:750444. doi: 10.3389/fbioe.2021.750444. eCollection 2021.
Circulating tumor cells (CTCs) play a crucial role in solid tumor metastasis, but obtaining high purity and viability CTCs is a challenging task due to their rarity. Although various works using spiral microchannels to isolate CTCs have been reported, the sorting purity of CTCs has not been significantly improved. Herein, we developed a novel double spiral microchannel for efficient separation and enrichment of intact and high-purity CTCs based on the combined effects of two-stage inertial focusing and particle deflection. Particle deflection relies on the second sheath to produce a deflection of the focused sample flow segment at the end of the first-stage microchannel, allowing larger particles to remain focused and entered the second-stage microchannel while smaller particles moved into the first waste channel. The deflection of the focused sample flow segment was visualized. Testing by a binary mixture of 10.4 and 16.5 μm fluorescent microspheres, it showed 16.5 μm with separation efficiency of 98% and purity of 90% under the second sheath flow rate of 700 μl min. In biological experiments, the average purity of spiked CTCs was 74% at a high throughput of 1.5 × 10 cells min, and the recovery was more than 91%. Compared to the control group, the viability of separated cells was 99%. Finally, we validated the performance of the double spiral microchannel using clinical cancer blood samples. CTCs with a concentration of 2-28 counts ml were separated from all 12 patients' peripheral blood. Thus, our device could be a robust and label-free liquid biopsy platform in inertial microfluidics for successful application in clinical trials.
循环肿瘤细胞(CTCs)在实体瘤转移中起着至关重要的作用,但由于其数量稀少,获得高纯度和高活力的CTCs是一项具有挑战性的任务。尽管已经报道了各种使用螺旋微通道分离CTCs的工作,但CTCs的分选纯度并未得到显著提高。在此,我们基于两阶段惯性聚焦和粒子偏转的联合效应,开发了一种新型双螺旋微通道,用于高效分离和富集完整的高纯度CTCs。粒子偏转依赖于第二鞘层在第一阶段微通道末端使聚焦的样品流段产生偏转,使较大的粒子保持聚焦并进入第二阶段微通道,而较小的粒子则进入第一废液通道。聚焦样品流段的偏转情况得以可视化。通过10.4和16.5μm荧光微球的二元混合物进行测试,结果表明在第二鞘层流速为700μl/min时,16.5μm微球的分离效率为98%,纯度为90%。在生物学实验中,在1.5×10个细胞/min的高通量下,加标的CTCs的平均纯度为74%,回收率超过91%。与对照组相比,分离细胞的活力为99%。最后,我们使用临床癌症血样验证了双螺旋微通道的性能。从所有12名患者的外周血中分离出浓度为2 - 28个/ml的CTCs。因此,我们的装置可以成为惯性微流控领域中一个强大的无标记液体活检平台,有望成功应用于临床试验。